NetraMark Holdings Inc. (TSX:AIAI)

Market Cap	84.85M -32.2%
Revenue (ttm)	165.26K -80.4%
Net Income	-5.80M
EPS	-0.07
Shares Out	92.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,017
Average Volume	34,378
Open	0.9300
Previous Close	0.9400
Day's Range	0.8800 - 0.9300
52-Week Range	0.8200 - 1.8000
Beta	1.48
RSI	39.57
Earnings Date	May 13, 2026

About NetraMark Holdings

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2016
• Country: Canada
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: AIAI

Financial Performance

In fiscal year 2025, NetraMark Holdings's revenue was 432,495, a decrease of -5.18% compared to the previous year's 456,127. Losses were -5.22 million, 56.7% more than in 2024.